The START Center for Cancer Research ("START") stands as the world’s largest early phase site network exclusively dedicated to oncology clinical research. Throughout our history, we’ve provided hope to cancer patients in community practices globally by offering access to cutting-edge trials across the US and Europe. With over 1,300 completed studies and research facilities in the United States, Spain, Portugal, and Ireland, START’s mission is to accelerate the development of new anticancer drugs that improve quality of life and survival for patients with cancer—ultimately leading to its cure. Our impact is undeniable: over 43 therapies conducted at START locations have obtained FDA/EMA approval. While Academic Medical Centers conduct 80% of cancer trials but reach only 20% of patients, START bridges this critical gap—bringing innovative cancer trials directly to physicians and their patients in community hospitals and practices when hope is needed most.
START represents the world’s largest roster of Principal Investigators across eight clinical trial sites. Committed to accelerating the journey from trials to treatments, we deliver hope to patients, families, and physicians worldwide. In San Antonio, where START was founded, we treated the first patient ever with Keytruda—now recognized as the most effective cancer drug in medical history.

JOIN OUR MISSION AS DIRECTOR, INVESTIGATIONAL DRUG SECTION (IDS) IN LAKE SUCCESS, LONG ISLAND, NY

Are you ready to transform cancer care at the forefront of clinical innovation? We’re seeking a visionary and experienced Director, Investigational Drug Section (IDS) to lead our pharmacy operations at our Lake Success, Long Island location. In this pivotal leadership role, you’ll champion our pharmacy operations while ensuring rigorous compliance with regulations and internal SOPs. This career-defining opportunity combines strategic leadership—developing pharmacy staff and optimizing daily operations—with hands-on clinical expertise that directly impacts groundbreaking cancer research and patient outcomes. Join us in pioneering tomorrow’s cancer treatments today.
The annual base salary for this role is $180,000 - $229,000, reflecting the significant expertise and leadership required. Your compensation may vary based on your unique qualifications, experience, and market factors.
Schedule: Monday through Friday, 8am-5pm

Please refer the Job description for details